摘要：

Lung cancer is the leading cause of death due to cancer in China. In recent years, great progress has been made in radiotherapy for lung cancer patients in China. The main advancements include the following aspects:(1) stereotactic ablative radiotherapy for early stage nonsmall cell lung cancer(NSCLC),(2) post-operative radiotherapy for NSCLC,(3) combined chemotherapy and radiotherapy for locally advanced NSCLC,(4) improved radiotherapy for advanced NSCLC, and 5) prediction of radiation-induced lung toxicity.

展开